PMID- 10517560 OWN - NLM STAT- MEDLINE DCOM- 19991201 LR - 20190513 IS - 0146-4760 (Print) IS - 0146-4760 (Linking) VI - 23 IP - 6 DP - 1999 Oct TI - Simultaneous determination of amphetamine, methamphetamine, methylenedioxyamphetamine (MDA), methylenedioxymethamphetamine (MDMA), and methylenedioxyethylamphetamine (MDEA) enantiomers by GC-MS. PG - 518-23 AB - A method is described for the simultaneous determination of the ratio of l- and d-enantiomers of amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxymethamphetamine (MDMA), and 3,4-methylenedioxyethylamphetamine (MDEA) in urine. The assay uses liquid-liquid extraction followed by derivatization with trifluoroacetyl-l-prolyl chloride (l-TPC) and analysis by gas chromatography-mass spectrometry. The assay was developed using prepared samples containing varying concentrations of each of the analytes over a range of percentages of each enantiomer. Results showed the method to provide accurate and reliable results in samples containing > or = 10 ng/mL amphetamine and methamphetamine and > or = 25 ng/mL MDA, MDMA, and MDEA. The assay was used to analyze urine samples from subjects of a controlled MDMA study. Results for each of the eight subjects showed a greater percentage of the l-enantiomer of MDMA initially, and the percentage increased with time postdose. Analysis of the metabolite MDA revealed that the proportion of d-enantiomer was initially greater than the l-enantiomer followed by a gradual increase in the proportion of l-enantiomer until it exceeded the amount of the d-enantiomer. In all cases, the l-MDA exceeded the d-MDA within the first 36 h postdose. FAU - Hensley, D AU - Hensley D AD - Clinical Research Squadron, Wilford Hall Medical Center, Lackland AFB, Texas 78236-5319, USA. FAU - Cody, J T AU - Cody JT LA - eng PT - Journal Article PL - England TA - J Anal Toxicol JT - Journal of analytical toxicology JID - 7705085 RN - 0 (Amphetamines) RN - 0 (Central Nervous System Stimulants) RN - 44RAL3456C (Methamphetamine) RN - 4764-17-4 (3,4-Methylenedioxyamphetamine) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) RN - ML1I4KK67B (3,4-methylenedioxyethamphetamine) SB - IM MH - 3,4-Methylenedioxyamphetamine/analogs & derivatives/urine MH - Amphetamines/*urine MH - Central Nervous System Stimulants/*urine MH - Gas Chromatography-Mass Spectrometry MH - Humans MH - In Vitro Techniques MH - Methamphetamine/urine MH - N-Methyl-3,4-methylenedioxyamphetamine/urine MH - Sensitivity and Specificity MH - Stereoisomerism MH - Substance Abuse Detection/*methods MH - Time Factors MH - Urine/*chemistry EDAT- 1999/10/12 00:00 MHDA- 1999/10/12 00:01 CRDT- 1999/10/12 00:00 PHST- 1999/10/12 00:00 [pubmed] PHST- 1999/10/12 00:01 [medline] PHST- 1999/10/12 00:00 [entrez] AID - 10.1093/jat/23.6.518 [doi] PST - ppublish SO - J Anal Toxicol. 1999 Oct;23(6):518-23. doi: 10.1093/jat/23.6.518.